These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37079073)

  • 1. Securing injection laryngoplasty with anti-reflux valve.
    Abdul Rahim N; Laurent I; Remacle M
    Eur Arch Otorhinolaryngol; 2023 Jun; 280(6):3027-3029. PubMed ID: 37079073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications of injection laryngoplasty using calcium hydroxylapatite.
    DeFatta RA; Chowdhury FR; Sataloff RT
    J Voice; 2012 Sep; 26(5):614-8. PubMed ID: 22056892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injection laryngoplasty outcomes in irradiated and nonirradiated unilateral vocal fold paralysis.
    Chang J; Courey MS; Al-Jurf SA; Schneider SL; Yung KC
    Laryngoscope; 2014 Aug; 124(8):1895-9. PubMed ID: 24473831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Very Rare Complication of Vocal Fold Augmentation With Calcium Hydroxylapatite: Neck Abscess.
    Madgar O; Primov-Fever A
    J Voice; 2023 Jan; 37(1):142.e1-142.e3. PubMed ID: 33153855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing voice impairment after injection laryngoplasty.
    Ting JY; Patel R; Halum SL
    J Voice; 2012 Nov; 26(6):797-800. PubMed ID: 22633331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of long-term voice outcomes after vocal fold augmentation using autologous fat injection by direct microlaryngoscopy versus office-based calcium hydroxylapatite injection.
    Zeleník K; Walderová R; Kučová H; Jančatová D; Komínek P
    Eur Arch Otorhinolaryngol; 2017 Aug; 274(8):3147-3151. PubMed ID: 28478500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of office-based percutaneous injection laryngoplasty with calcium hydroxylapatite.
    Lee M; Lee DY; Kwon TK
    Laryngoscope; 2019 Oct; 129(10):2361-2365. PubMed ID: 30756397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Office-based injection laryngoplasty for the management of unilateral vocal fold paralysis.
    Verma SP; Dailey SH
    J Voice; 2014 May; 28(3):382-6. PubMed ID: 24491502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous pressure measurement and serial micro-computed tomography analysis during injection laryngoplasty: A preliminary canine cadaveric study.
    Kim MS; An S; Jin S; Kim T; Kwon TK
    PLoS One; 2020; 15(9):e0239544. PubMed ID: 32966339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 24-month voice outcomes after injection laryngoplasty with calcium hydroxylapatite or hyaluronic acid in patients with unilateral vocal fold paralysis.
    Miaśkiewicz B; Panasiewicz A; Nikiel K; Włodarczyk E; Gos E; Szkiełkowska A
    Am J Otolaryngol; 2022; 43(1):103207. PubMed ID: 34537510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis on the efficiency of the injection laryngoplasty technique using calcium hydroxyapatite (CaHA): the thyrohyoid approach versus the cricothyroid approach.
    Woo SH; Son YI; Lee SH; Park JJ; Kim JP
    J Voice; 2013 Mar; 27(2):236-41. PubMed ID: 23280385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injection laryngoplasty outcomes in vocal fold paralysis using calcium hydroxylapatite.
    Koçdor P; Tulunay-Uğur ÖE
    Kulak Burun Bogaz Ihtis Derg; 2014; 24(5):271-5. PubMed ID: 25513870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic vocal fold injection using a 25-gauge butterfly needle.
    Buchanan MA; Riffat F; Palme CE
    J Laryngol Otol; 2016 Apr; 130(4):398-400. PubMed ID: 26879799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paediatric injection medialisation laryngoplasty: Recent Great Ormond Street Hospital experience.
    Stephenson KA; Cavalli L; Lambert A; Fleming J; Lawes E; Gupta S; Jephson CG; Cochrane LA
    Int J Pediatr Otorhinolaryngol; 2017 Sep; 100():86-90. PubMed ID: 28802393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of injection force mechanics during injection laryngoplasty.
    Pearson JJ; Ortiz AS; Montelongo S; Simpson CB; Guda T; Dion GR
    Laryngoscope; 2019 May; 129(5):1060-1066. PubMed ID: 30421428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of injectable calcium hydroxylapatite in the surgically pretreated larynx with glottal insufficiency.
    Caffier PP; I Nasr A; Weikert S; Rummich J; Gross M; Nawka T
    Laryngoscope; 2017 May; 127(5):1125-1130. PubMed ID: 27578371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Office-based Autologous Fat Injection Laryngoplasty for Vocal Process Granuloma.
    Hu HC; Hung YT; Lin SY; Chang SY
    J Voice; 2016 Nov; 30(6):758.e7-758.e11. PubMed ID: 26454769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Office-based vocal fold injection with the laryngeal introducer technique.
    Clary MS; Milam BM; Courey MS
    Laryngoscope; 2014 Sep; 124(9):2114-7. PubMed ID: 24577997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Operating room versus office-based injection laryngoplasty: a comparative analysis of reimbursement.
    Bové MJ; Jabbour N; Krishna P; Flaherty K; Saul M; Wunar R; Rosen CA
    Laryngoscope; 2007 Feb; 117(2):226-30. PubMed ID: 17204989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent Vocal Fold Granuloma Following Superficial PAAG Injection Laryngoplasty: A Case Report.
    Kang KY; Lee SA; Lee SK; Seon SW; Jung JH; Park KN; Kwak JJ; Lee SW
    J Voice; 2016 Nov; 30(6):769.e19-769.e21. PubMed ID: 26743606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.